Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

NIR- and Multifrequent Impedance Spectroscopy on the Skin in Type 1 Diabetes (NIR)

This study has been completed.
Information provided by (Responsible Party):
Lise Tarnow, Steno Diabetes Center Identifier:
First received: September 25, 2012
Last updated: October 15, 2012
Last verified: October 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)